| Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib C Sun, P Nierman, EK Kendall, J Cheung, M Gulrajani, SEM Herman, ... Blood, The Journal of the American Society of Hematology 136 (1), 93-105, 2020 | 85 | 2020 |
| NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts D Zhang, HM Harris, J Chen, J Judy, G James, A Kelly, J McIntosh, ... Blood 141 (13), 1584-1596, 2023 | 15 | 2023 |
| Specialized prenatal care delivery for coronavirus disease 2019–exposed or–infected pregnant women SK Dotters-Katz, H Harris, SM Wheeler, GK Swamy, BL Hughes American Journal of Obstetrics & Gynecology 224 (3), 325-327, 2021 | 4 | 2021 |
| Highly potent BTK degradation induced by NRX0492 as a therapeutic strategy for CLL D Zhang, H Harris, A Kelly, DW Robbins, M Tan, T Ingallinera, N Bence, ... Blood 134, 174, 2019 | 2 | 2019 |
| Risk Factors for Adverse Maternal Outcomes following Expectantly Managed Preterm Prelabor Rupture of Membranes AJ Darling, HM Harris, GE Zemtsov, M Small, MR Grace, S Wheeler, ... American Journal of Perinatology 39 (08), 803-807, 2022 | 1 | 2022 |
| Beta-blocker and ACE-inhibitor dosing as a function of body surface area: From the HF-ACTION trial JA Brooksbank, SJ Greene, HM Harris, A Stebbins, M Fiuzat, DJ Whellan, ... American Heart Journal 233, 1-4, 2021 | 1 | 2021 |
| Discussion on the renal tubules. H Harris, J ANDERSON, F STRANACK Proceedings of the Royal Society of Medicine 48 (10), 777-783, 1955 | 1 | 1955 |
| The genomic architecture of ibrutinib resistance in CLL: Oligoclonal progression with variable anatomical distribution C Underbayev, J Chen, HM Harris, LT Vaughn, A Itsara, A Wiestner Cancer Research 84 (6_Supplement), 5828-5828, 2024 | | 2024 |
| Medical Student Duty Hours and Shelf Performance: Is There a Correlation? BS Harris, HM Harris, MA Baldwin, SK Dotters-Katz American Journal of Perinatology, 2023 | | 2023 |
| Complement Shields Fc Regions on HIT Immune Complexes and Prevents Recognition By Cellular Fcγ Receptors H Harris, S Khandelwal, L Rauova, J Lambris, B Garcia, DB Cines, ... Blood 140 (Supplement 1), 8372-8373, 2022 | | 2022 |
| Predictors of blood transfusion among patients admitted with early severe pre-eclampsia JL Dillon, H Harris, G Zemtsov, AM Craig, MR Grace, SK Dotters-Katz American Journal of Obstetrics & Gynecology 226 (1), S696, 2022 | | 2022 |
| 773 Risk factors for adverse maternal outcomes following expectantly managed preterm prelabor rupture of membranes AJ Darling, H Harris, G Zemtsov, SM Wheeler, M Grace, M Small, ... American Journal of Obstetrics & Gynecology 224 (2), S482-S483, 2021 | | 2021 |
| Cohorting prenatal care during the COVID-19 pandemic HM Harris, SK Dotters-Katz, S Wheeler, GK Swamy, B Hughes American Journal of Obstetrics & Gynecology 223 (6), 985, 2020 | | 2020 |
| Whole Exome Sequencing Reveals Multiple Driver Events in Chronic Lymphocytic Leukemia Patients with Acquired Ibrutinib Resistance C Underbayev, IE Ahn, H Harris, LT Vaughn, M Pirooznia, L Xi, M Raffeld, ... Blood 134, 1287, 2019 | | 2019 |
| PATHOLOGIE CHIMIQUE 467 H HARRIS Proceedings, 467, 1956 | | 1956 |
